Erez Meltzer

AI
Building infrastructure for accessible preventive imaging
Nanox CEO and Acting Chairman of the Board Erez Meltzer shares the company's vision for the future of preventive imaging.
November 20, 2025
Nanox ARC.X 3D tomosynthesis system.
Page 1 of 1
Top Stories
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Womens Imaging
Radiologists can designate nonmass lesions on breast ultrasound
Coronavirus
MRI
Long COVID's neurological effects persist
Obesity Text2
MRI
MRI proves effective for tracking results of obesity interventions
Phpt
Molecular Imaging
TVR-PET/CT shows promise in primary hyperparathyroidism
More in Authors
Chris Wood
November 19, 2025
Chris Wood
Erik Jacobsson
November 18, 2025
Erik Jacobsson
Giuseppe Scappatura
September 10, 2025
Giuseppe Scappatura
John Memarian
August 18, 2025
John Memarian
Angela Adams
August 5, 2025
1697891335052
Jordan Bazinsky
June 12, 2025
Jordan Bazinsky New Headshot (final)
Sanjeev Bhalla, MD, and Mensur Koso, MD
May 8, 2025
Deborah Barnes
June 7, 2024
Erik L. Ridley
October 4, 2010
Erik Ridley
Page 1 of 1